Tianeptine Impurity E, identified by its CAS number 768351-55-9, is a chemical compound associated with the pharmaceutical tianeptine, which is primarily used as an antidepressant. As an impurity, it may arise during the synthesis or degradation of tianeptine and is typically characterized by its structural and chemical properties that differ from the parent compound. While specific details about its physical and chemical properties may not be widely documented, impurities like Tianeptine Impurity E can influence the efficacy and safety profiles of pharmaceutical formulations. Generally, impurities are assessed for their potential biological activity, toxicity, and stability under various conditions. Regulatory agencies often require thorough characterization and quantification of such impurities to ensure the quality and safety of pharmaceutical products. Understanding the characteristics of impurities is crucial in the context of drug development and quality control, as they can impact the overall therapeutic outcomes and patient safety.

Tianeptine Impurity E

768351-55-9: Tianeptine Impurity E, identified by its CAS number 768351-55-9, is a chemical compound associated with the pharmaceutical tianeptine, which is primarily used as an antidepressant. As an impurity, it may arise during the synthesis or degradation of tianeptine and is typically characterized by its structural and chemical properties that differ from the parent compound. While specific details about its physical and chemical properties may not be widely documented, impurities like Tianeptine Impurity E can influence the efficacy and safety profiles of pharmaceutical formulations. Generally, impurities are assessed for their potential biological activity, toxicity, and stability under various conditions. Regulatory agencies often require thorough characterization and quantification of such impurities to ensure the quality and safety of pharmaceutical products. Understanding the characteristics of impurities is crucial in the context of drug development and quality control, as they can impact the overall therapeutic outcomes and patient safety.

CAS 768351-55-9

Tianeptine Impurity E

Tianeptine EP Impurity E

Ref: 4Z-T-3611

Tianeptine Sodium EP Impurity E

Ref: ST-EA-CP-T113007